Search for: "Matter of Noonan"
Results 21 - 40
of 304
Sort by Relevance
|
Sort by Date
20 Apr 2023, 8:46 pm
Noonan -- An appellant's burden on appeal is never easy but it is particularly difficult when the questions at issue are based on factual evidence. [read post]
20 Nov 2022, 9:55 pm
Noonan -- Last week, IP Law360 published an erudite and provocative article by Joseph Matal and his colleagues regarding the Supreme Court's recent subject matter jurisprudence in the context of earlier decisions in the 19th and early 20th Centuries (see "How Mayo V. [read post]
5 Oct 2022, 8:12 pm
Noonan -- The Federal Circuit affirmed the Patent Trial and Appeal Board's (PTAB) Final Written Decision (FWD) in an inter partes review (IPR) that Mylan Pharmaceuticals failed to show the claims of U.S. [read post]
10 Aug 2022, 11:18 am
Or, for that matter, civil liability. [read post]
3 Aug 2022, 7:31 pm
Noonan -- Senator Thom Tillis (R-NC) introduced S. 4734, entitled "A Bill to amend Title 35, U.S. [read post]
26 Jul 2022, 9:30 pm
Noonan -- Kathi Vidal, Under Secretary of Commerce for Intellectual Property and Director of the U.S. [read post]
12 Jul 2022, 11:44 am
And that is what truly matters, right? [read post]
7 Jul 2022, 2:05 pm
In Murphy v IRTC Barrington J gave two examples of the common good: the case concerned a ban on religious advertising in section 10(3) of the Radio and Television Act, 1988 (also here), and Barrington J (at [30]) held that the ban in section 10(3) could be justified either to prevent public unrest, or to ensure that, in matters of sensitivity, rich people “should not be able to buy access to the airwaves to the detriment of their poorer rivals”. [read post]
30 Jun 2022, 11:06 am
Noonan -- In a month where the Supreme Court's conservative majority has exercised its judicial muscle by striking down several well-established precedents, one portion of their jurisprudence is as fixed a constant as the Northern Star: the Court will not address the morass in patent subject matter eligibility created by the decisions in Bilski, Mayo, Alice, and Myriad, and once again refused to do so in American Axle & Mfg. [read post]
15 Jun 2022, 8:43 pm
Noonan -- On May 23rd, U.S. [read post]
8 May 2022, 3:29 am
No matter how much commentators like The Wall Street Journal’s Peggy Noonan warn them, “Do not, as large dumb misogynists, start waxing on about how if a woman gets an illegal abortion she can be jailed. [read post]
5 May 2022, 5:30 am
While giving an honorary lecture at the University of Texas Law School where I was then teaching, Judge John Noonan went so far as to throw a copy of Constitutional Fate from the podium into the audience in an expression of angry disdain for my Roe arguments and, apart from adverse book reviews at the time, I am unaware of anyone who has even bothered to discuss my views on the matter. [read post]
24 Mar 2022, 7:40 pm
Noonan -- As posted Monday, BIO (the Biotechnology Innovation Organization) provided a link to the supposed compromise agreement reached recently to permit WTO member states to waive patent protection for "subject matter required for the production and supply of COVID-19 vaccines without the consent of the right holder to the extent necessary to address the COVID-19 pandemic. [read post]
15 Feb 2022, 9:03 pm
Noonan -- The 2020 decision by a divided Federal Circuit panel in GlaxoSmithKline LLC v. [read post]
30 Dec 2021, 9:11 pm
Noonan -- While the Federal Circuit has patent law as its principal focus, as a U.S. [read post]
22 Dec 2021, 8:51 pm
Noonan -- The issue of standing can be outcome-determinative: without it, no matter how worthy a party's position or arguments, a court will not consider them without standing. [read post]
28 Nov 2021, 9:14 pm
Noonan -- The Leahy-Smith America Invents Act prescribed two very different post-grant review proceedings in U.S. patent law. [read post]
16 Nov 2021, 9:59 pm
Noonan -- The Federal Circuit continued its stringent (if misguided) application of the scope of subject matter eligibility by invalidating claims asserted in CardioNet, LLC v. [read post]
7 Nov 2021, 9:50 pm
In the webinar, entitled "Accepting the Status Quo: Subject Matter Eligibility Nearly a Decade after Mayo," Kevin Noonan and Donald Zuhn Jr. of McDonnell Boehnen Hulbert & Berghoff LLP will moderate a panel consisting of Cara Coburn of Genentech, June Cohan of the U.S. [read post]
7 Nov 2021, 9:50 pm
In the webinar, entitled "Accepting the Status Quo: Subject Matter Eligibility Nearly a Decade after Mayo," Kevin Noonan and Donald Zuhn Jr. of McDonnell Boehnen Hulbert & Berghoff LLP will moderate a panel consisting of Cara Coburn of Genentech, June Cohan of the U.S. [read post]
